biOasis Technologies Ord Shs V.BTI.H

Primary Symbol: BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by neinsteinon Aug 27, 2015 10:51pm

180 Views

Post# 24058175

RE:RE:TSX Listing versus TSX Venture

Eunice i would expect that at this exact time BTI is not devoting much in the way of resources towards the TSX (and/or NASDAQ) listing issue. It is however an important issue as after any deal, which is the most likely method of filling the treasury by a sufficient amount to move up, the market will need institutional interest to make any meaningful move higher. Many institutions are restricted from buying venture listed companies. So, i think it is worthy of discusssion . . . while we wait for news . . . unless you have something more interesting to discuss?

nein

Bullboard Posts

Understanding different debt management strategies (good debt vs. bad debt)